A plasma membrane protein called dopamine transporter (DAT) mediates extracellular dopamine (DA) reuptake and regulates the spatiotemporal dynamics of dopaminergic neurotransmission. DATs are essential for stopping dopaminergic signaling and preserving a dopamine pool that can be released. DATs actively shuttle released transmitter molecules back across the plasma membrane into dopaminergic neurons, where they can be sequestered for later use or enzymatic catabolism. This helps to modulate the concentration of extraneuronal dopamine.
DAT is the primary target of a number of psychostimulants, nootropics, antidepressants, and some recreational drugs, such as the notoriously addictive stimulant cocaine. Cocaine-like inhibitors and amphetamine-like substrates are the two categories into which DAT ligands have traditionally been divided. A number of signaling systems, including PKC, control DAT.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V71787 | (R)-Phenylpiracetam (MRZ 9547) | 949925-07-9 | (R)-Phenylpiracetam (MRZ 9547) is a dopamine transporter (DAT) inhibitor (antagonist) with Ki and IC50 of 14.8 μM and 65.5 μM respectively. |
|
V71786 | 13-Hydroxyisobakuchiol (Delta3,2-Hydroxylbakuchiol) | 178765-49-6 | 13-Hydroxyisobakuchiol (Delta3,2-Hydroxylbakuchiol) is extracted from Psoralea corylifolia and is an analog of Bakuchiol. |
|
V71788 | 3-CPMT (Tropine 4-chlorobenzhydryl ether hydrochloride) | 14008-79-8 | 3-CPMT (Tropine 4-chlorobenzyl ether HCl) is a potent dopamine uptake inhibitor. |
|
V71785 | 5,7-Dimethoxyluteolin | 90363-40-9 | 5,7-Dimethoxyluteolin, a 5,7-dimethylluteolin analogue, is a dopamine transporter (DAT) activator with EC50 of 3.417 μM. |
|
V99861 | AC-4-248 | AC-4-248 is an atypical noncompetitive dopamine transporter (DAT) inhibitor that reduces the inhibitory potency of cocaine on DAT. | |
|
V71784 | AHN 1-055 hydrochloride (3α-Bis-(4-fluorophenyl) Methoxytropane hydrochloride) | 202646-03-5 | AHN 1-055 HCl is a dopamine uptake inhibitor (antagonist) with IC50 of 71 nM. |
|
V70652 | CAD031 | 2071209-49-7 | CAD031 is an analogue of the AD/Alzheimer's disease targeting agent J147 with neuro-protection and memory-enhancing properties. |
|
V85137 | DAT-IN-1 | ||
|
V70004 | Desipramine-d3 (desipramine hydrochloride-d3; desipramine hydrochloride-d3) | 65100-49-4 | Desipramine-d3 is deuterium labelled Desipramine. |
|
V70006 | Desipramine-d4 (desipramine hydrochloride-d4; desipramine hydrochloride-d4) | 61361-34-0 | Desipramine-d4 is the deuterium labelled form of Desipramine. |
|
V2046 | GBR 12935 | 76778-22-8 | GBR-12935 is a novel, potent and selective dopamine reuptake inhibitor. |
|
V94477 | GBR 12935 fumarate | 1349767-56-1 | GBR 12935 fumarate is a potent and selective dopamine reuptake inhibitor with a binding constant Kd of 1.08 nM for the dopamine transporter in COS-7 cells. |
|
V2045 | GBR 12935 HCl | 67469-81-2 | GBR-12935 is a novel, potent and selective dopamine reuptake inhibitor and a piperazine derivative. |
|
V87836 | IP2015 | 1320346-14-2 | IP2015 is a monoamine reuptake inhibitor that inhibits the reuptake of dopamine, serotonin (5-HT), and norepinephrine. |
|
V84731 | JJC12-009 | ||
|
V92285 | JJC8-088 | 1627576-82-2 | JJC8-088 is a potent DAT inhibitor. |
|
V101210 | JJC8-088 dioxalate | 2068692-71-5 | JJC8-088 dioxalate is the dioxalate salt form of JJC8-088. |
|
V100272 | JJC8-089 | 1627576-64-0 | JJC8-089 is a dopamine transporter (DAT) inhibitor that improves motivational impairment and increases effortful behavior during goal-directed activities. |
|
V84783 | JJC8-091 | 1627576-76-4 | |
|
V101687 | LH2-051 | 2358754-22-8 | LH2-051 is a lysosome-enhancing lead compound that promotes lysosomal biogenesis and clearance of Aβ aggregates via the dopamine transporter-cyclin-dependent kinase 9-transcription factor EB (DAT-CDK9-TFEB) pathway. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
